000 01449 a2200445 4500
005 20250514042524.0
264 0 _c20020920
008 200209s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.59.4.649
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTribl, G G
245 0 0 _aNormal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome.
_h[electronic resource]
260 _bNeurology
_cAug 2002
300 _a649-50 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter; Comment
650 0 4 _aBenzamides
650 0 4 _aCircadian Rhythm
650 0 4 _aContrast Media
650 0 4 _aCorpus Striatum
_xdiagnostic imaging
650 0 4 _aDopamine Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevodopa
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyrrolidines
650 0 4 _aReceptors, Dopamine D2
_xanalysis
650 0 4 _aRestless Legs Syndrome
_xdiagnostic imaging
650 0 4 _aTomography, Emission-Computed, Single-Photon
700 1 _aAsenbaum, S
700 1 _aKlösch, G
700 1 _aMayer, K
700 1 _aBonelli, R M
700 1 _aAuff, E
700 1 _aZeitlhofer, J
700 1 _aHappe, S
773 0 _tNeurology
_gvol. 59
_gno. 4
_gp. 649-50
856 4 0 _uhttps://doi.org/10.1212/wnl.59.4.649
_zAvailable from publisher's website
999 _c12078228
_d12078228